Profile data is unavailable for this security.
About the company
ROHTO PHARMACEUTICAL CO., LTD. is a Japan-based company principally engaged in the health and beauty care area. The Company primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The Company operates its business in domestic market and overseas markets, including Europe, Asia and America.
- Revenue in JPY (TTM)270.84bn
- Net income in JPY30.94bn
- Incorporated1949
- Employees7.18k
- LocationRohto Pharmaceutical Co Ltd1-8-1, Tatsumi-Nishi, Ikuno-kuOSAKA-SHI 544-8666JapanJPN
- Phone+81 667581231
- Websitehttps://www.rohto.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nxera Pharma Co Ltd | 16.43bn | -9.07bn | 130.54bn | 350.00 | -- | 1.97 | -- | 7.94 | -107.30 | -107.30 | 194.96 | 736.60 | 0.1309 | -- | 5.77 | 46,954,280.00 | -7.23 | -0.6588 | -7.78 | -0.7036 | 74.44 | 89.83 | -55.20 | -4.46 | 4.03 | -10.91 | 0.5238 | -- | -18.00 | -- | -1,982.98 | -- | -- | -- |
| Towa Pharmaceutical Co Ltd | 227.93bn | 16.17bn | 148.88bn | 4.30k | 8.80 | 0.9125 | 6.02 | 0.6532 | 328.58 | 328.58 | 4,630.88 | 3,167.26 | 0.5684 | 1.51 | 3.66 | -- | 4.03 | 4.21 | 5.03 | 5.63 | 35.70 | 39.23 | 7.10 | 7.23 | 1.46 | -- | 0.5649 | 20.79 | 9.13 | 16.74 | 634.80 | 3.72 | 28.20 | 10.86 |
| Kissei Pharmaceutical Co Ltd | 75.58bn | 11.16bn | 155.08bn | 1.80k | 12.76 | 0.6319 | 9.98 | 2.05 | 246.57 | 246.57 | 1,669.95 | 4,977.43 | 0.3135 | 1.56 | 2.94 | -- | 4.68 | 3.61 | 5.05 | 3.90 | 49.41 | 49.47 | 14.94 | 12.69 | 4.43 | -- | 0.006 | 34.69 | 11.98 | 0.8919 | 6.00 | 15.28 | 6.58 | 10.40 |
| KAKEN PHARMACEUTICAL CO., LTD. | 72.04bn | 8.03bn | 164.23bn | 1.13k | 16.80 | 0.9418 | 18.76 | 2.28 | 212.76 | 212.76 | 1,909.11 | 3,796.04 | 0.4264 | 2.05 | 3.37 | -- | 4.75 | 6.83 | 5.40 | 7.87 | 53.49 | 54.78 | 11.14 | 14.48 | 4.72 | -- | 0.0261 | 51.19 | -1.29 | -5.21 | 47.52 | -14.70 | 0.3639 | 0.00 |
| Nippon Shinyaku Co., Ltd. | 148.25bn | 25.85bn | 215.88bn | 2.19k | 8.01 | 0.9398 | 6.99 | 1.46 | 383.80 | 383.80 | 2,201.16 | 3,269.71 | 0.592 | 1.33 | 3.25 | -- | 10.32 | 10.45 | 12.09 | 12.31 | 66.12 | 61.27 | 17.44 | 16.47 | 3.35 | -- | 0.0129 | 32.62 | 2.83 | 5.26 | 13.32 | 9.66 | 45.93 | 12.12 |
| Peptidream Inc | 27.97bn | 2.44bn | 255.99bn | 603.00 | 104.48 | 6.38 | 52.26 | 9.15 | 18.85 | 18.85 | 215.77 | 308.51 | 0.4323 | 4.20 | 5.14 | 46,391,190.00 | 3.77 | -- | 4.38 | -- | 59.16 | -- | 8.73 | -- | 3.23 | 2.59 | 0.3505 | -- | 6.93 | -- | -59.81 | -- | -- | -- |
| Sawai Group Holdings Co Ltd | 176.86bn | 17.22bn | 267.73bn | 3.39k | 15.59 | 1.26 | 8.71 | 1.51 | 392.06 | 311.79 | 4,029.61 | 4,854.95 | 0.474 | 1.21 | 2.85 | -- | 3.40 | 0.7104 | 4.60 | 0.9705 | 30.71 | 35.08 | 7.17 | 1.47 | 1.50 | 52.16 | 0.2755 | 88.14 | 8.04 | -0.8249 | 46.82 | -2.33 | 18.15 | 0.00 |
| Tsumura & Co | 150.85bn | 16.71bn | 303.20bn | 4.03k | 17.97 | 1.11 | 10.53 | 2.01 | 219.81 | 219.81 | 1,984.75 | 3,566.54 | 0.3657 | 0.748 | 2.42 | -- | 4.37 | 4.81 | 5.43 | 5.89 | 45.62 | 50.98 | 11.96 | 12.65 | 2.39 | -- | 0.2125 | 32.09 | 7.71 | 4.52 | 1.37 | 2.74 | 17.54 | 5.84 |
| Hisamitsu Pharmaceutical Co Inc | 141.71bn | 13.97bn | 318.18bn | 2.76k | 20.65 | 1.07 | 16.23 | 2.25 | 180.93 | 180.93 | 1,840.27 | 3,497.04 | 0.441 | 3.13 | 3.43 | 51,361,360.00 | 4.49 | 4.22 | 5.25 | 4.82 | 55.73 | 58.62 | 10.18 | 10.03 | 3.76 | -- | 0.0078 | 53.05 | 10.42 | -0.2385 | 18.97 | -6.17 | 28.90 | 0.5989 |
| Kobayashi Pharmaceutical Co Ltd | 176.47bn | 17.71bn | 423.73bn | 3.53k | 23.22 | 1.97 | 17.54 | 2.40 | 233.81 | 233.81 | 2,340.20 | 2,757.18 | 0.6865 | 3.13 | 4.90 | 49,935,770.00 | 6.89 | 8.01 | 8.53 | 10.18 | 55.53 | 56.45 | 10.03 | 12.24 | 2.19 | -- | 0.0046 | 33.19 | 4.33 | 0.7037 | 1.58 | 2.45 | 29.67 | 8.88 |
| Santen Pharmaceutical Co Ltd | 301.97bn | 26.63bn | 592.59bn | 4.14k | 22.27 | 1.93 | 13.20 | 1.96 | 73.11 | 73.11 | 830.17 | 842.64 | 0.7048 | 2.99 | 3.11 | -- | 6.23 | 3.31 | 7.90 | 4.10 | 59.18 | 59.73 | 8.84 | 5.21 | 2.08 | 5.12 | 0.16 | 81.86 | 8.22 | 5.23 | 278.09 | -3.58 | 5.10 | 4.88 |
| Rohto Pharmaceutical Co Ltd | 270.84bn | 30.94bn | 652.09bn | 7.18k | 20.42 | 2.56 | 19.86 | 2.41 | 135.21 | 135.21 | 1,183.69 | 1,079.72 | 0.8259 | 2.59 | 4.17 | -- | 9.57 | 8.54 | 13.02 | 11.79 | 58.07 | 58.59 | 11.59 | 10.30 | 1.93 | -- | 0.0408 | 19.39 | 13.48 | 8.09 | 17.28 | 25.85 | 5.20 | 18.61 |
| Ono Pharmaceutical Co Ltd | 502.67bn | 127.98bn | 1.13tn | 3.76k | 8.55 | 1.35 | 7.76 | 2.26 | 265.98 | 265.98 | 1,046.97 | 1,688.42 | 0.5597 | 2.72 | 4.11 | -- | 14.26 | 11.95 | 16.44 | 13.73 | 74.71 | 74.11 | 25.47 | 23.89 | 3.52 | -- | 0.011 | 32.11 | 12.41 | 11.73 | 13.53 | 19.95 | -6.79 | 12.20 |
Data as of Jun 04 2024. Currency figures normalised to Rohto Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
24.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| MFS International (UK) Ltd.as of 30 Apr 2024 | 12.28m | 5.20% |
| SPARX Asset Management Co., Ltd.as of 15 Feb 2023 | 11.71m | 4.96% |
| The Vanguard Group, Inc.as of 09 May 2024 | 6.93m | 2.93% |
| Nomura Asset Management Co., Ltd.as of 30 Apr 2024 | 6.88m | 2.92% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 4.39m | 1.86% |
| Fidelity Management & Research Co. LLCas of 30 Apr 2024 | 3.77m | 1.60% |
| Nikko Asset Management Co., Ltd.as of 10 May 2024 | 3.10m | 1.31% |
| Daiwa Asset Management Co. Ltd.as of 30 Apr 2024 | 2.88m | 1.22% |
| Artisan Partners LPas of 31 Mar 2024 | 2.55m | 1.08% |
| BlackRock Fund Advisorsas of 09 May 2024 | 2.28m | 0.97% |
More ▼
Data from 31 Dec 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
